Research & Discovery
Dr. Cato T. Laurencin Elected to the European Academy of Sciences
The prestigious European Academy of Sciences has recognized UConn's Dr. Cato T. Laurencin for his visionary and pioneering work in the field of regenerative engineering
OVPR Announces SPARK Technology Commercialization Fund Recipients for 2022-23
Five researchers were awarded internal funding through the competitive program.
“Catching Up” in Secondary Math Education: Areas to Focus Your Efforts
Kenya Overton and Andrew Kuck, Neag School of Education doctoral students in the Department of Curriculum and Instruction, prepared the following rapid research brief on secondary math education with the Center for Education Policy Analysis, Research, and Evaluation (CEPARE).
Nearly $3 Million Awarded to Study Sickle Cell Disease at UConn Health
June 19 is World Sickle Cell Day. Pioneering physician-scientist Dr. Marja Hurley has been awarded nearly $3 million in research funding to discover more scientific insights about bone loss in sickle cell disease.
Science in Seconds: Our Immunity vs E. coli
A UConn Health immunology researcher is focusing on the interaction between our immune system and E. coli to better understand it and develop new treatments against this potentially deadly disease.
A Fresh Take on Fat: Nanoparticle Technology Provides Healthy Trans, Saturated Fat Alternative
An innovative emulsification process could help scientists develop a healthier shelf-stable fat for food manufacturing
A Perfect Storm for US Agriculture
Short-term solutions to the current crunch are conspicuous by their absence
Understanding Elastins to Develop Therapies for Aging-Related Conditions
CAREER Award-winning engineering professor Anna Tarakanova seeks to understand how therapies targeting elastins - the proteins that tissue and organs need to stretch - can improve the lives of aging adults
Herbarium Milestone: Preserving our Past, Present, and Future
'This is a record of the natural history of the state'
Breaking Barriers – the First Patient in the World Receives Moderna mRNA Trial Infusion for Glycogen Storage Disease at UConn Health
Loveah Hernandez, a brave 20-year-old from Texas, is contributing to science as the first person in the world to receive the Moderna mRNA infusion as part of the Ba1ance Trial for GSD-Ia at UConn Health.